![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20211101005129/en/Tarveda-Therapeutics-Announces-Data-from-Phase-2-Trial-of-PEN-221-to-Be-Presented-at-NANETS-2021-Multidisciplinary-NET-Virtual-Symposium
https://www.biospace.com/article/releases/tarveda-therapeutics-to-present-data-from-phase-2-study-of-pen-221-at-2021-asco-annual-meeting/
https://www.businesswire.com/news/home/20200804005646/en/Tarveda-Therapeutics-Publishes-Preclinical-Study-Evaluating-HSP90
https://www.tarvedatx.com/4-27-20-tarveda-presents-pharmacokinetic-and-tumor-biopsy-data-from-first-in-human-study-of-pen-866
https://www.businesswire.com/news/home/20200407005816/en/Tarveda-Therapeutics-Update-Proposed-Merger-Organovo